U.S. Department of Health & Human Services
National Institutes of Health
NCATS
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
GIRENTUXIMAB
539B57DFJF
Investigational
General
Record Details
Names
10
Classification
4
Identifiers
9
Subunits
4
Disulfide Links
16
Glycosylation
2
Relationships
2
Active Moiety
1
Characteristic Attributes
2
GIRENTUXIMAB
539B57DFJF
Investigational
General
Approval Year
Unknown
139,594
Record Details
Substance Class
Protein
Protein Type
MONOCLONAL ANTIBODY
Protein Sub Type
IGG1
Sequence Origin
MOUSE CHIMERIC
Sequence Type
COMPLETE
Record UNII
539B57DFJF
Record Status
Validated (UNII)
Record Version
24
23
22
21
20
19
18
17
16
15
14
13
12
11
10
9
8
7
6
5
4
3
2
1
Names
10
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
GIRENTUXIMAB
Official Name
English
GIRENTUXIMAB [USAN]
Common Name
English
RENCAREX
Brand Name
English
girentuximab [INN]
Common Name
English
Girentuximab [WHO-DD]
Common Name
English
Showing 1 to 5 of 10 entries
Previous
1
2
Next
Classification
4
Show
5
20
100
All
entries
Classification Tree
Code System
Code
Classification Tree
Code System
Code
Antineoplastic Biological Agent
Pharmacologic Substance
[C1909]
Biological Agent
[C307]
Antineoplastic Biological Agent
[C129821]
Antineoplastic Antibody
NCI_THESAURUS
C129822
Designated/Withdrawn
ORPHAN DRUG
Designated/Withdrawn
Treatment of renal cell carcinoma.
FDA ORPHAN DRUG
139000
Biological Agent
Pharmacologic Substance
[C1909]
Biological Agent
[C307]
Monoclonal Antibody
NCI_THESAURUS
C20401
Designated/Withdrawn
ORPHAN DRUG
Designated/Withdrawn
Treatment of renal cell carcinoma.
FDA ORPHAN DRUG
133300
Showing 1 to 4 of 4 entries
Previous
1
Next
Identifiers
9
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
USAN
WW-150
PRIMARY
INN
9116
PRIMARY
ChEMBL
CHEMBL1743027
PRIMARY
CAS
916138-87-9
PRIMARY
NCI_THESAURUS
C1960
PRIMARY
Showing 1 to 5 of 9 entries
Previous
1
2
Next
Subunits
4
Disulfide Links
16
Show
5
20
100
All
entries
From
To
From
To
1_22
1_96
1_146
1_202
1_263
1_323
1_369
1_427
2_22
2_96
Showing 1 to 5 of 16 entries
Previous
1
2
3
4
Next
Glycosylation
2
Show
5
20
100
All
entries
Glycosylation Link Type
Site
Glycosylation Link Type
Site
N
1_299
N
2_299
Showing 1 to 2 of 2 entries
Previous
1
Next
Relationships
2
Show
5
20
100
All
entries
Related Record
Type
Details
Related Record
Type
Details
P0I0FT82VK
GIRENTUXIMAB I-124
INGREDIENT -> STARTING MATERIAL
A0JY916TKK
CARBONIC ANHYDRASE 9
TARGET -> INHIBITOR
Showing 1 to 2 of 2 entries
Previous
1
Next
Active Moiety
1
Show
5
20
100
All
entries
Related Record
Type
Details
Related Record
Type
Details
539B57DFJF
GIRENTUXIMAB
ACTIVE MOIETY
Showing 1 to 1 of 1 entries
Previous
1
Next
Characteristic Attributes
2
Show
5
20
100
All
entries
Name
Property Type
Amount
Referenced Substance
Defining
Parameters
References
Name
Property Type
Amount
Referenced Substance
Defining
Parameters
References
MOL_WEIGHT:NUMBER(CALCULATED)
CHEMICAL
ESTIMATED 146000 Da (average)
Molecular Formula
CHEMICAL
ESTIMATED
C6460H9982N1718O2018S48
Showing 1 to 2 of 2 entries
Previous
1
Next
